Review Open Access Logo

Tobacco Smoking and Cancer Types: A Review

Yousef Khani 1
Nima Pourgholam-Amiji 2
Mohammad Afshar 3
Omid Otroshi 4
Mehran Sharifi-Esfahani 5
Hamidreza Sadeghi-Gandomani 6
Marjan Vejdani 7
Hamid Salehiniya 8, 9, *
  1. Deputy of Health, Alborz University of Medical Sciences, Karaj, Iran
  2. School of Nursing & Midwifery, Tehran University of Medical Sciences, Tehran, Iran
  3. Department of Operating Room, School of Nursing and Midwifery, Kashan University of Medical Sciences, Kashan, Iran
  4. School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  5. Department of Oncology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  6. Trauma Nursing Research Center, School of Nursing and Midwifery, Kashan University of Medical Sciences, Kashan, Iran
  7. Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences, Sabzevar, Iran
  8. Zabol University of Medical Sciences, Zabol, Iran
  9. Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran
Correspondence to: Hamid Salehiniya, Zabol University of Medical Sciences, Zabol, Iran; Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran. Email: [email protected].
Volume & Issue: Vol. 5 No. 4 (2018) | Page No.: 2142-2159 | DOI: 10.15419/bmrat.v5i4.428
Published: 2018-04-16

Online metrics


Statistics from the website

  • HTML Views: 34372
  • PDF Views: 4198
  • XML Views: 0

Statistics from Dimensions

Copyright The Author(s) 2024. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Objective: Tobacco smoking is one of the causes of the incidence and mortality of cancer in the world. This study aimed to review the relationship between TS and especially the use of cigarettes with common cancers of various organs of the body.

Methods: This study was  conducted  in  English by November 2017 through a search in databases of the PubMed, Scopus and Web of Science. The search strategy included the key words "cancer", "tobacco smoke", "tobacco smoke", and "smoking." Articles that looked at the relationship between each type of cancer and smoking were entered into the study and summarized in Review.

Results: Tobacco smoking is associated with an increased risk of lung cancer, Upper aerodigestive tract, esophagus, stomach, bladder, kidneys, colorectal, prostate, and pancreas. However, further studies are needed to confirm the association between Tobacco smoking and liver, cervical, brain, gallbladder, Hodgkin’s disease, non-Hodgkin’s lymphoma and hematologic malignancies. However, Tobacco smoking plays a protective role in the development of thyroid cancers, skin and Kaposi’s sarcoma.

Conclusions: Given that almost all of the risk factors for most cancers are Tobacco smoking, increasing the public’s awareness of the harmful effects of smoking, implementing programs and policies to  reduce smoking, can lead to a reduction in smoking and consequently reduce  the  resulting  harmful  consequences.

Introduction

Tobacco smoking (TS) is one of the causes of the incidence and mortality of cancer in the world [1]. It is responsible for about 25% of all cancers in men, 4% of all cancers in women and about 16% of all cancers in both sexes in most developed countries and 10% in less developed countries [2]. In the United States, approximately 40% of the cancers diagnosed is related to tobacco consumption [3]. According to recent research evidence, tobacco causes a lot of cases of lung cancer [4]. It is the leading cause of cancers of oral and throat, vocal cords, esophagus, stomach, kidneys, pancreas, liver, bladder, cervix, colon and rectum, and types of leukemia [2][5][6][7][8]. According to the Center for Cancer Prevention (CDC), tobacco-related cancers have been diagnosed between 2008 and 2013 for some 660000 people in the United States, but 343,000 of these people have died [9].

It seems that only small organs in the TS have been immune to cancer. Available evidence has shown that there is an inverse relationship between endometrium cancer and TS [2]. Evidence also suggests that the association between TS and liver cancer has not been definitively confirmed. Confounding variables such as hepatitis B and C can affect this relationship [10]. Given the numerous studies on smoking and cancer, this study aimed to review the relationship between TS and especially the use of cigarettes with common cancers of various organs of the body, taking into account possible confounding variables for each organ based on available evidence and review of the literature.

Methods

This study was conducted in English by November 2017 to include epidemiological evidence from all available randomized control trials, case-control and cohort studies reporting tobacco- related cancer risks through a search in databases of the PubMed, Scopus and Web of Science. The search strategy included the key words "cancer", "tobacco smoke", and "smoking." In addition, the reference lists of relevant articles were manually searched to find any other potentially eligible articles. Articles about smoking intensity are also included in the present study. We excluded reviews, commentaries, articles from overlapping samples, conference abstracts, and articles printed in languages other than English. Articles that looked at the relationship between each type of cancer and smoking were entered into the study and summarized in review. Most studies evaluated exposure to tobacco smoke quantitatively by reporting number of cigarettes per day, duration of smoking or age at starting to smoke, or in a cumulative way in terms of pack years 3 (number of packs of cigarettes smoked daily multiplied by the number of years of smoking). Similarly, the benefit of smoking cessation was evaluated either in comparing risks in former smokers with those in current smokers, or as a trend by years since quitting to smoke.

Results

Study characteristics

In the initial electronic literature search, 2540 articles were obtained from databases and 12 articles were obtained using manual search. After removing duplicates using Endnote X7 (n =1200), the title and abstract of the remaining 1340 articles were reviewed. After this stage, 191 articles were included in the study and 1164 of these articles were removed because of scientific reasons and lack of eligible criteria or unrelated to our aim, in all, 176 full papers were reviewed.

The most important cancers related to Tobacco Smoking are summarized in Table 1 .

Table 1

Relationship between TobaccoSmoking and Cancer Types.

Lung

One of the main causes of lung cancer (LC) is TS (4). Smokers are at risk to LC approximately 20 times more than people who have never smoked regularly. Smoking is responsible for 80% of LC in men and 50% of LC in women [11] . TS is associated with the incidence of small lung carcinoma (SCLC) and squamous cell carcinoma (SCC) [12]. Cigarette smoke contains about 20 potentially dangerous carcinogens and 3,500 chemical substances. The most common LC-induced chemicals found in cigarette smoke are polycyclic aromatic hydrocarbons (PAH) like benzo (a) pyrenes, and the tobacco-specific N-nitrosamine 4- (methylnitrosamino) -1- (3-pyridyl) -1-butanone NNK) [13]. Cigarette smoke also contains high levels of acrolin, which damages ciliated lining of the lung and helps to develop LC. Nitrogen oxides, acetaldehyde, phenols and formaldehyde are substances in cigarette smoke that indirectly contribute to LC [12]. Free radicals in cigarette smoke also cause oxidative damage in human and animal studies and contribute to the development of LC [14]. The risk of LC in the second hand smokers is also high [15] LC risk is 20-30% higher in non-smokers who marry smokers compared with others [11][16][17]. The risk of LC in heavy and continuous smokers is 20 to 50 times higher than non-smokers [18]. The most important risk index for LC is the duration of smoking [11].

Upper aerodigestive tract (UADT)

UADT cancers include oral, pharyngeal, hypopharynx, larynx, esophagus, nasal cavities, nasal sinuses, pharynx and adenocarcinoma of esophagus [2][19]. The findings of a case-control study in 10 European countries showed in 2009 compared to non-smokers, TS is associated with a risk of UADT in general (OR: 6.72; 95% CI, 5.45-8.30), oral cavity cancer (OR: 5.83; 95% CI; 4.5-7.54), pharyngeal cancer (OR: 12.19; 95% CI, 8.29-17.92), and laryngeal and hypopharyngeal cancer (OR: 4017; 95% CI, 2.45-7.10 for esophagus) [19]. The findings of the meta-analysis study also showed that non-selective involuntary exposure to tobacco is associated with head and neck cancers, especially throat and larynx [20]. Based on a review study of nine case-control studies and a cohort study on sinonasal cancer, this type of cancer is associated with increased TS. Also, TS is also associated with a significant decrease in sinonasal cancer [2]. A finding from a study by Bosetti et al. (2007) showed that discontinuation of smoking at any age has reduced the risk of UADT incidence [21].

Esophagus

One of the major risk factors for esophageal cancer is TS [22]. The relationship between TS and esophageal cancer has been reported since 1985. It is also has been mainly related to squamous cell carcinoma of esophagus [2]. The findings of several case-control studies showed that TS is one of the proven risk factors for esophageal cancer [23][24][25]. Findings from several studies showed that the risk of developing ESCC in smokers is 3-7 times higher than non-smokers [26][27]. According to a 2012 meta-analysis study, about 20-30% of esophageal cancer patients were addicted to cigarette smoking [28]. However, limited studies have directly evaluated the role of cigarette as a prognostic factor in esophageal cancer (22). Numerous studies in the United States, the incidence of esophageal adenocarcinoma in the United States and Britain in smokers has increased steadily compared with non-smokers. This process has been relatively constant for the squamous cell carcinoma and even has had a decreasing [29][30].

Stomach

One of the known causes of stomach cancer is TS [31]. A systematic review study on 23 epidemiologic studies investigated the relationship between TS and stomach cancer with 10,290 cases and 26,145 controls revealed that compared to non-smokers, Odd Ratio(OR) for ever was

1.20 (95% CI: 1.09-1.32), OR for former smokers 1.12 (95% CI: 0.99-1.27) and OR for current smokers 1.25 (95% CI: 1.11-1.40). Also, with an increase in TS duration, the incidence of stomach cancer was significantly higher (OR, 95.1% CI 95% CI: 1.14-1.54) [32]. The findings of the cohort showed more than 215,000 men and women of the five ethnic groups (African Americans, Japanese Americans, Latino Americans, Native Hawaiians, and Whites), for all five racial groups, the rate of stomach cancer in smoker men (HR = 1.98; 95% CI 1.46-2.70) and in smoker women (HR = 1.78; 95% CI 1.23-2.57) was higher than non-smokers [33]. The findings of meta-analysis on cohort studies showed tobacco is one of the most important risk factors for stomach cancer [31]. The findings of a systematic review study on 10 cohort studies and 6 case-control studies revealed that there is a positive and strong association between TS and stomach cancer in men and there is a positive and weak correlation between TS and stomach cancer in women [34]. Since the middle of the last century, the incidence and mortality rate of stomach cancer in most of the high-income countries has declined [35][36]. Reducing the incidence of stomach cancer can be due to a reduction in the prevalence of smoking in men [31]. A positive association between TS and stomach cancer can be affected by confounding variables such as the infection of the stomach and the helicobacter pylori infection [37]. However, the association is not well known and confirmed [2].

Liver

Cohort and case-control studies have investigated the relationship between TS and liver cancer. Often, these studies have been conducted in areas where liver cancer is high, such as Southeast Asia and Europe [38,39]. Majority of these studies reported that the incidence of liver cancer among smokers was higher than non-smokers [40]. Other risk factors, such as hepatitis B or C and high alcohol intake, also play an important role in the development of liver cancer. Controlling these variables as a confounder also adjust the association between TS and liver cancer [39]. The International Agency for Research on Cancer also lists liver cancer in the list of tobacco- related malignancies [40]. A systematic review of 12 cohort studies showed that smoking is associated with an increase in the rate of liver cancer. However, there were no mention of potential confounders such as hepatitis B and C virus in these studies. In this study, 11 case-control studies were also studied and the findings showed that among the 11 case-control studies, 5 studies reported poor to moderate association between smoking and liver cancer, and the relation of dose response was only in one study. In the remaining 5 studies, the observed relationship was inverse or null due to the lack of data on the dose response variable [10]. Meta-analytical study findings in 2009 also supported the association between cigarette smoking and liver cancer [40].

Bladder

The risk of developing bladder cancer in smokers is 2 to 4 times more than non-smokers [41]. By increasing the amount and duration of smoking, the risk increases in both sexes [42–44]. Risk in people who use non-smoked cigarettes with high tar or black tobacco is more than those who use filtered cigarettes and golden tobacco with low tar [42]. Second-hand smokers have a 30-60% lower risk compared to smokers [18]. Smoking is responsible for 23% of BC in women and 50% of BC in men [45]. Following the discontinuation of smoking, the risk of bladder cancer decreases by 30-20% within 5 years. Recently, it has been argued that women may have more risk at bladder cancer due to TS [41]. The precise method of developing BC is not clear by the use of cigarettes. BC risk seems to be related to some of the chemicals found in cigarettes such as naphthylamine-2 and aminobiphenyl-4, polycyclic aromatic hydrocarbons [46]. Tobbaco combustion release at least 69 carcinogens including nitrosamine, polycyclicaromatic hydrocarbon, 2-naphthylamine and other aromatic amines, all of which are directly responsible for the role of mutagens in BC formation [47]. Also, the main routes of induction of cancer in smokers are the DNA adduct formation and genetic damage. They cause the change of specific cellular pathways, and subsequently uncontrolled cell growth and prevention of the activity of internal mechanisms inhibiting tumor growth [48].

Cervix

Smoking is one of the known risk factors for cervical cancer [49]. This role of smoking is independent of sexual behavior. some studies have shown a positive and significant relationship between the number of cigarettes consumed and the duration of smoking, and the incidence of cervical cancer. It seems that there is less danger in those who have left smoking [50][51]. However, other studies have not been able to relate their findings to smoking [52]-[54]. Meta-analysis findings in women with human papillomavirus revealed that smokers were twice as likely to have cervical cancer as non-smokers [55]. Cohort study findings in women with human papillomavirus also indicated that the risk of cervical cancer in women smokers and those who had previously smoked and now left smoking was at least three times more likely than other women [56]. The effect of direct TS carcinogens on cervix is based on the fact that nicotine metabolites can be 6 found in the cervical mucus of women who smoke [57]. Another acceptable mechanism is the suppression of local immune responses to human papillomavirus infection [58][59]. In general, further studies are needed to confirm the definitive effects of TS on the incidence of oral cancer.

Kidney

The findings of the epidemiological studies have shown the association between TS and the incidence of pelvis cancer. TS, especially cigarettes, has increased the risk of developing kidney cancers by 20%, which is seen more in middle-aged and elderly people. Cigarette smoking increases the risk of developing renal cell carcinoma (RCC). Meta-analysis study findings showed that the increased risk is associated with the number of cigarettes consumed [60]. The findings of another meta-analysis study showed that current smokers are at a 3 to 4-fold higher risk of developing urinary cancers than others. According to the study, in Europe about half of the cases of urinary tract cancer are detected in men and one third of women are attributed to TS [61]. With the cessation of smoking, the risk is reduced, but many years of time are needed to be as same as the risk level of people who quit smoking than the risk in people who have never smoked. The findings of several narrative studies have also recognized the significant role of smoking in the incidence of urinary tract cancer [62][63].

Blood Cancers

TS is not a risk factor for the risk of malignancies, but some epidemiological evidence supports the claim that TS is a risk factor for leukemia [64]. Some cohort and case studies have shown an increase in the incidence of hematologic malignancies, especially non- lymphoblastics, among smokers, while other studies have not shown significant correlation. However, the findings of Brownson et al (1993) [65], Siegel (1993) [66] and Sandler (1995) [67] showed that, despite the discrepancy in various studies, there is evidence that the relationship Between TS and the development of blood malignancies. TS contains about 3800 chemical substances, most of which are mutagenic and carcinogenic [68] and contain radioactive compounds and benzene, both of which are known carcinogens in the development of leukemia [2][68]]69]. It is estimated that smokers inhale benzene 10 times more than non-smokers [64]. Smoke also contains nitrosamines and urethane, which cause leukemia in animals, and also contain styrene and agricultural chemicals that are a potential source of leukemia in humans [68]. Available evidence also suggests that there is a relationship between TS and myeloid leukemia, and the risk increases with increasing the duration and amount of cigarette smoking [2].

Colorectal

Smoking, and in particular smoking, is a common risk factor for CRC in both genders [70]. Cohort studies in Korea showed that CRC risk was higher in non-smokers than in non-smokers [71]. Findings from the meta-analysis studies suggest a positive relationship between smoking, and colorectal adenoma and colorectal cancer. The findings from comprehensive systematic review of batteri et al. showed a significant relationship between smoking and the occurrence of adenoma polyps, which are pre-cancerous lesions of colorectal cancer [72]. The meta-analysis findings by Chen et al showed that smoking is a major risk factor for colorectal cancer [73]. Another study found that CRC risk increased in people who smoked over 45 years, while there was no increase in the number of cigarette packs with CRC risk [74]. moking is responsible for 20% of all types of CRC in the United States [75]. Several studies also found that smoking has increased the risk of CRC by up to 30% in smokers and women [76][78].

Prostate 7

Based on the findings of Paler et al., 2013, the incidence and death rate of PCa increased significantly with the increase in smoking [79]. Various mechanisms have been proposed for prostate cancer due to smoking [79][80]. Among the known mechanisms of tobacco use, it is possible to increase serum estrogen metabolites, and subsequently stimulation of an invasive tumor phenotype, which ultimately leads to prostate cancer [81].

Pancreas

One of the most important risk factors for pancreatic cancer is smoking [82][83]. Meta-analysis study findings revealed that the risk of pancreatic cancer in smokers is 2 times that of non- smokers. The risk of cancer is positively correlated with an increase in the number of cigarettes and duration of use [84]. About 20-30% of cases of pancreatic cancer are due to smoking. Most importantly, the risk of pancreatic cancer in people who leave smoking is reduced to near normal levels [85][86]. The findings of a meta-analysis study on 82 cohort studies and case-control cases published between 1950 and 2007 show that in current smokers, the relative risk (RR) of pancreatic septicemia is 1.7 (95% confidence interval [CI] 1.6-1.9) and in former smokers 1.2 (95% CI 1.1- 1.3) [84] . According to the international cohort study, the pancreatic cancer included 1481 cases and 1539 controls, RR in former smokers was 1. 1 (95% CI 0.9-1.3) and in current smokers was 1.8 (95% CI 1.4-2.3). This risk was also associated with an increase in the number of cigarettes and the duration of use. As in individuals who smoked 30 or more doses daily, RR was 1.75 and in those who smoked at least 50 years, while in people who had left smoking for more than 15 years, RR was similar to those who never smoked [87].

Brain

Two types of common brain tumors are glioma and meningioma, accounting for approximately 75% of all brain tumors [88]. There is contradictory evidence regarding the relationship between smoking and gliomas or meningitis. In smokers, tobacco smoke is the largest source of N-nitroso compounds [89][90]. These compounds are associated with the development of tumors in the nervous system in animals [90][91]. Despite the role of nicotine in increasing the blood brain barrier permeability [92], whether N-nitrose penetrates into the brain or not is still unknown [93]. Considering that TS causes cancer in various organs of the body, tobacco smoke is thought to be effective in treating brain tumors [88]. However, the findings of most case-control studies have not shown evidence of increased glioma risk associated with TS [94][96]. Some other studies have shown RR increases, but these findings are not meaningful or limited to specific population subgroups [97][99]. In cohort studies, some findings also did not report a relationship between TS and brain tumors [100][102], while others reported a meaningful relationship only in women [103][104]. Meta-analysis study findings have recently shown that there is no relationship between cigarette smoke and glioma in general, though there was a slight, but significant increase in one cohort study entered into the analysis. For meningioma, some case-control studies did not report evidence of increased risk [96][102][105][108], and other studies reported association only in one sex [95][109][110]. In sum, there is no clear evidence of the link between tobacco smoke and glioma and meningitis, and further studies are needed.

Gallbladder

Researchers believe that TS affects hepatobiliary system and is associated with increased risk of gallbladder cancer [111][112]. However, studies on the association between gallbladder disease and gallstone risk are as a mix. Several case-study and cross-sectional descriptive studies did not confirm the association [113][115] or even inverse relationship [116], while quantitative studies showed increased risk [117][118]. Some findings from these studies seem to be influenced by the selection or recall biased. Therefore, the final conclusion based on such studies is difficult and further studies are needed with more robust design, such as cohort studies.

Hodgkin’s disease

TS is one of the potential risk factors for the classic Hodgkin’s lymphoma (CHL), which requires careful examination. Despite the limited number of studies in this regard, the findings of these studies are inconsistent. The findings of some studies have shown a significant decrease [119], some lack of association [120][123], and some significant increases [124][126] in overall HL risk in smokers. On the other hand, the discrepancy in the findings may be due to various methodological issues, including the low sample size of the study, the biases associated with the selection of the group, and the participants in the study and the uncontrollable confounders. Recently, the findings of three meta-analysis studies showed that TS increased the overall risk of HL [127][129]. Overall, it can be concluded that TS is one of the moderating risk factors for CHL types.

Non-Hodgkin’s Lymphoma

The findings of the early epidemiological studies on the role of smoking in non-Hodgkin’s lymphoma have been disconnected. Some studies reported that smoking was associated with the incidence of this cancer [130][134], while others found that there was no relationship between cigarette smoke and non-Hodgkin’s lymphoma [135][140]. Meta-analysis study findings in 2005 indicated that smoking is associated with a slight increase in non-Hodgkin’s lymphoma (OR, 1.07; 95% CI, 1.00-1.15) [141]. Although smoking is generally unrelated to the risk of non-Hodgkin’s lymphoma, there is much evidence that smoking can be associated with the follicular lymphoma subtype, especially in women [126][142][145]. More recently, cohort study findings showed that people who were exposed to tobacco smoke 40 years or more became 50%more likely to develop non-Hodgkin’s lymphoma than those who smoked 5 years or less [146]. There are more studies with more robust design like cohort studies in this area.

Kaposi’s Sarcoma

Kaposi’s sarcoma is a relatively rare type of skin cancer that is common in humans. It is not activated in the normal state of the body, it can be considered an opportunistic disease [147]. The common feature of these diseases is its suppression by the immune system in the normal state of the body and its activation in the event of immunodeficiency. Unlike other cancers that smoke is a risk factor for them, it is known as a protective agent in this cancer [147][148]. However, many studies have not been done in this area.

The findings of the case-control study showed that there is a correlation between current cigarette smoking and a reduction in the incidence of Kaposi’s sarcoma (OR, 0.20; 95% CI, 0.06-0.67) [149]. This inverse relationship is supported by reducing the risk of lung cancer in these patients [150][153]. In a cohort study, Nawar etal reported a lower relative risk (OR, 0.6, 95% CI, 0.5-0.9) in the incidence of Acquired Immune Deficiency Syndrome (AIDS) and Kaposi’s syndrome in smokers [147]. Immunological effects of smoking are thought to reduce the risk of Kaposi’s sarcoma. For example, nicotine can affect dendrite cellular function [154][155], and may cause cytokine changes and produce growth factor involved in Kaposi’s sarcoma development [156]. However, according to a clinical trial that used nicotine skin patches for 15 weeks to improve skin lesions of Kaposi’s sarcoma, it showed a small effect of nicotine [155]. Also, the findings of Guttman et al. And Conley et al. did not confirm the inverse relationship between smoking and Kaposi’s sarcoma [157][158]. In general, given that most patients with Kaposi’s sarcoma are often at an advanced age, their use of cigarettes increases the incidence of smoking- related illnesses and increases the mortality of these patients and thus cannot be considered as a completely protective factor to be considered [149]. On the other hand, in order to confirm the protective effect of smoking, the need for more comprehensive cohort studies is felt.

Skin

Skin cancer is one of the most common and prevalent types of cancers in humans. Three major types of skin malignancies include basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma [148]. TS contains several carcinogenic compounds that affect at least 18 types of cancers [159] but have a reversible relationship with skin malignancies. Smoking can reduce the blood flow of the skin and stop the immune response, which increases the risk of skin cancer [160]; on the other hand, it can protect the inflammatory response induced by UV radiation and, therefore, reduce it. Risk of skin cancer [161][165]. his effect of smoking is relatively due to the prolonged effects of nicotine accumulation in human tissues that contain melanin [166]. Various studies have shown that transdermel delivery of nicotine suppresses inflammatory responses to sodium lauryl sulphate and UV-B [167][168]. Cohort study findings showed that in male ever smokers had less common risk of developing melanoma (RR = 0.72; 95% CI: 0.58-0.86) and BCC (RR = 0.94; 95) compared to those who never smoked. However, there was no significant relationship with SCC (RR = 0.99; 95% CI: 1.03-1.08) [148]. Findings from Mills Case Studies [168] and Kessides [164] also suggest that cigarette smoking has an inverse association with melanoma, although this relationship was not significant. Another study found that there was an insignificant decrease in the incidence of melanoma in men who were ever smokers (RR = 0.6; 95% CI: 0.3-1.1), but not seen in women (RR = 1.0; 95% CI: 0.3-1.1. [169].

Thyroid

There is some evidence that smoking is a significant modifiable treatment that affects thyroid cancer. The findings of several case-control [170][173] and prospective [173][174] studies have shown that there is an inverse association between thyroid cancer and smoking, but some studies did not confirm this relationship [175][177]. The findings of a meta-analysis study on five cohort studies indicate that there is an inverse association between current cigarette smoking and the risk of thyroid cancer. Based on this study, if the severity and duration of smoking is low in former smokers [178], the risk will be less. The findings of another meta-analysis study showed that the risk of thyroid cancer in current smokers decreased by 40% [179]. Compared to people who have never smoked or smoked, current smokers have lower levels of thyroid stimulating hormone (TSH) [180][181], Triiodothyronine (T3) [181] and thyroxine (T4) [180] and a lower prevalence of serum autistic thyroiditis [180]. T3, T4 and especially TSH play a major role in thyroid cancer [178][182]. Smoking is also effective in changing the levels of sex steroid hormones on thyroid cancer [183][184].

Conclusion

The purpose of this review study was to investigate the relationship between TS and especially smoking and common cancers. Based on the results of studies, TS is associated with an increased risk of lung cancer, Upper aerodigestive tract, esophagus, stomach, bladder, kidneys, colorectal, prostate, and pancreas. However, further studies are needed to confirm the association between TS and liver, cervical, brain, gallbladder, Hodgkin’s disease, non-Hodgkin’s lymphoma and hematologic malignancies. However, TS plays a protective role in the development of thyroid cancers, skin and Kaposi’s sarcoma. Given that almost all of the risk factors for most cancers are TS, increasing the public’s awareness of the harmful effects of smoking, implementing programs and policies to reduce smoking, can lead to a reduction in smoking and consequently reduce the resulting harmful consequences. There are also some limitations in this study. This review is not a systematic review and only English articles were reviewed.

List of abbreviations

AIDS: Acquired Immune Deficiency Syndrome; BCC: Basal cell carcinoma; CDC: Center for Cancer Prevention; CHL: Classic Hodgkin’s lymphoma; CRC: Colorectal Cancer; LC: Lung cancer; PCa: Prostate cancer; RR: Relative risk; RCC: Renal cell carcinoma; SCLC: Small lung carcinoma; SCC: Squamous cell carcinoma; T4: Thyroxine; TS: Tobacco smoking; T3: Triiodothyronine; UADT: Upper aerodigestive tract.

Authors’ contributions

All authors contributed to the design of the research, Y.K, N.P.A, M.A, O.O, M.SE, extracted the data and summarized it. All authors drafted the first version. HSG, M.V and HS edited the first draft. All authors reviewed, commented and approved the final draft.

Open Access

This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Competing interests

The authors declare that no competing interests exist.

References

  1. for Disease CC Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs-united States, 1995-1999. MMWR. Morbidity and Mortality Weekly Report 2002; 51300-3.
  2. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 2004; (AmsterdamNetherlands) 45-
  3. Statistics N. National vital statistics report. 2016;
  4. Pope CA, Burnett RT, Turner MC, Cohen A, Krewski D, Jerrett M. Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. Environmental Health Perspectives 2011; 1191616-21.
  5. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 1441252-61.
  6. Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer 2010; EpidemiologyBiomarkers & Prevention 19-
  7. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. Journal of the National Cancer Institute 2010; 1021012-22.
  8. Gandomani HS, Tarazoj AA, Salehiniya H. Cigarette: The Silent Killer in the World. Biomedical Research and Therapy 2017; 41624-8.
  9. Centers for Disease Control Prevention . Classification of Diseases, Functioning, and Disability. https://wwwcdcgov/media/releases/2016/p1110-vital-signs-cancer-tobacco.html 2016; 206
  10. Tanaka K, Tsuji I, Wakai K, Nagata C, Mizoue T, Inoue M, for the DRG, of Cancer Prevention Strategies in JE. Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. Japanese Journal of Clinical Oncology 2006; 36445-56.
  11. Sadeghi-Gandomani H, Asgari-Tarazoj A, Ghoncheh M, Yousefi SM, Delaram M, Salehiniya H. Lung cancer in the world: the incidence, mortality rate and risk factors. World cancer research journal 2017; 4
  12. Furrukh M. Tobacco smoking and lung cancer: perception-changing facts. Sultan Qaboos University Medical Journal 2013; 13345-58.
  13. Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ. Lung cancer in never smokers-a review. European Journal of Cancer 2012; (OxfordEngland) 48-
  14. Kligerman S, White C. Epidemiology of lung cancer in women: risk factors, survival, and screening. AJR. American Journal of Roentgenology 2011; 196287-95.
  15. Vineis P, Hoek G, Krzyzanowski M, Vigna-Taglianti F, Veglia F, Airoldi L. Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environmental Health 2007; 67-
  16. Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ (Clinical Research Ed.) 1997; 315980-8.
  17. Boffetta P. Involuntary smoking and lung cancer. Scandinavian Journal of Work, Environment & Health 2002; 2830-40.
  18. Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. 1959. International Journal of Epidemiology 2009; 381175-91.
  19. Lee YC, Marron M, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H. Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case- control study. Cancer 2009; EpidemiologyBiomarkers & Prevention 18-
  20. Wyss A, Hashibe M, Chuang SC, Lee YC, Zhang ZF, Yu GP. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. American Journal of Epidemiology 2013; 178679-90.
  21. Bosetti C, Gallus S, Peto R, Negri E, Talamini R, Tavani A. Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers. American Journal of Epidemiology 2008; 167468-73.
  22. Kuang J, min Jiang Z, xian Chen Y, peng Ye W, Yang Q, zhong Wang H, rong Xie D. Smoking exposure and survival of patients with esophagus cancer: a systematic review and meta-analysis. Gastroenterology research and practice 2016 2016;
  23. Tramacere I, Vecchia CL, Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology (Cambridge, Mass.) 2011; 22344-9.
  24. Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J. Epidemiology of esophageal cancer in Japan and China. Journal of Epidemiology 2013; 23233-42.
  25. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 2010; 5939-48.
  26. Morita M, Kumashiro R, Kubo N, Nakashima Y, Yoshida R, Yoshinaga K. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. International Journal of Clinical Oncology 2010; 15126-34.
  27. Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M, Scotti L. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. International Journal of Cancer 2011; 1292473-84.
  28. Ferronha I, Bastos A, Lunet N. Prediagnosis lifestyle exposures and survival of patients with gastric cancer: systematic review and meta-analysis. European Journal of Cancer Prevention 2012; 21449-52.
  29. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. Journal of the National Cancer Institute 2010; 1021344-53.
  30. Zhang ZF, Kurtz RC, Marshall JR. garette smoking and esophageal and gastric cardia. 1997;
  31. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes & Control 2008; 19689-701.
  32. Pelucchi C, Lunet N, Boccia S, Zhang ZF, Praud D, Boffetta P. The stomach cancer pooling (StoP) project: study design and presentation. European Journal of Cancer Prevention 2015; 2416-23.
  33. Nomura AM, Wilkens LR, Henderson BE, Epplein M, Kolonel LN. The association of cigarette smoking with gastric cancer: the multiethnic cohort study. Cancer Causes & Control 2012; 2351-8.
  34. Nishino Y, Inoue M, Tsuji I, Wakai K, Nagata C, Mizoue T, for the DRG, of Cancer Prevention Strategies in JE. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Japanese Journal of Clinical Oncology 2006; 36800-7.
  35. Malvezzi M, Bonifazi M, Bertuccio P, Levi F, Vecchia CL, Decarli A. An age-period-cohort analysis of gastric cancer mortality from 1950 to 2007 in Europe. Annals of Epidemiology 2010; 20898-905.
  36. Schottenfeld D, Fraumeni JF. Cancer epidemiology and prevention. 2006;
  37. IAfRo C. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. In v. 42: Silica and some silicates 1987;
  38. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127S5-16.
  39. Chuang SC, Vecchia CL, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Letters 2009; 2869-14.
  40. Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, Straif K. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. International Journal of Epidemiology 2009; 381497-511.
  41. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89630-9.
  42. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. Journal of the American Medical Association 2011; 306737-45.
  43. Escudero DO, Shirodkar SP, Lokeshwar VB. Bladder carcinogenesis and molecular pathways. Bladder Tumors 2011;
  44. The Scripps Research Institute. Bladder Cancer, [Internet] [cited 29 june]. 2017;
  45. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World Journal of Urology 2004; 21392-401.
  46. Gandomani HS, Tarazoj AA, Siri FH, Rozveh AK, Hosseini S, Borujeni NN. Essentials of bladder cancer worldwide: incidence, mortality rate and risk factors. Biomedical Research and Therapy 2017; 41638-55.
  47. null null. 2012 Bladder cancer risk from occupational and environmental exposures. Urologic Oncology: Seminars and Original Investigations 2012;
  48. Alberg AJ, Hebert JR. Cigarette smoking and bladder cancer: a new twist in an old saga?. 2009;
  49. Vet HC, Sturmans F, Knipschild PG. The role of cigarette smoking in the etiology of cervical dysplasia. Epidemiology (Cambridge, Mass.) 1994; 5631-3.
  50. Brisson J, Morin C, Fortier M, Roy M, Bouchard C, Leclerc J. Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions. American Journal of Epidemiology 1994; 140700-10.
  51. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. British Journal of Cancer 2000; 821332-8.
  52. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. The New England Journal of Medicine 1992; 3271272-8.
  53. Olsen AO, Gj?en K, Sauer T, rstavik I, Naess O, Kierulf K. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. International Journal of Cancer 1995; 61312-5.
  54. Schiff M, Becker TM, Masuk M, van Asselt-King L, Wheeler CM, Altobelli KK. Risk factors for cervical intraepithelial neoplasia in southwestern American Indian women. American Journal of Epidemiology 2000; 152716-26.
  55. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Research 2002; 89191-9.
  56. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. Journal of the National Cancer Institute 2002; 941406-14.
  57. Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Research 1987; 473886-8.
  58. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus. 1995;
  59. Cox JT. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus. Baillieres´ Clinical Obstetrics and Gynaecology 1995; 91-37.
  60. Zeegers M, Tan FE, Dorant E, van den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk. Cancer 2000; 89630-639.
  61. Chyou PH, Nomura AM, Stemmermann GN. A prospective study of diet, smoking, and lower urinary tract cancer. Annals of Epidemiology 1993; 3211-6.
  62. SL J, SM C. Epidemiology and etiology of bladder cancer. In Seminars in surgical oncology 1997;
  63. Shirai T, Fradet Y, Huland H, Bollack C, Droller M, Janknegt R. The etiology of bladder cancer-are there any new clues or predictors of behavior?. International Journal of Urology 1995; 264-75.
  64. Pasqualetti P, Festuccia V, Acitelli P, Collacciani A, Giusti A, Casale R. Tobacco smoking and risk of haematological malignancies in adults: a case-control study. British Journal of Haematology 1997; 97659-62.
  65. Brownson RC, Novotny TE, Perry MC. Cigarette smoking and adult leukemia. A meta- analysis. Archives of Internal Medicine 1993; 153469-75.
  66. Siegel M. Smoking and leukemia: evaluation of a causal hypothesis. American Journal of Epidemiology 1993; 1381-9.
  67. Sandler DP. Recent studies in leukemia epidemiology. Current Opinion in Oncology 1995; 712-8.
  68. Magnani C, Pastore G, Luzzatto L, Terracini B. Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkins´ lymphomas in childhood: a case-control study. Tumori 1990; 76413-9.
  69. Vineis P, Caporaso N. Tobacco and cancer: epidemiology and the laboratory. Environmental Health Perspectives 1995; 103156-60.
  70. Pasqualetti P, Casale R, Colantonio D, Collacciani A. Occupational risk for hematological malignancies. American Journal of Hematology 1991; 38147-9.
  71. Gandomani HS, Aghajani M, Mohammadian-Hafshejani A, Tarazoj AA, Pouyesh V, Salehiniya H. Colorectal cancer in the world: incidence, mortality and risk factors. Biomedical Research and Therapy 2017; 41656-75.
  72. Kim HJ, Lee SM, Choi NK, Kim SH, Song HJ, Cho YK, Park BJ. Smoking and colorectal cancer risk in the Korean elderly. Journal of preventive medicine and public health= Yebang Uihakhoe chi 2006; 39123-129.
  73. Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008; 134388-395e3.
  74. Chen K, Qiu JL, Zhang Y, Zhao YW. Meta analysis of risk factors for colorectal cancer. World Journal of Gastroenterology 2003; 91598-600.
  75. Cho S, Shin A, Park SK, Shin HR, Chang SH, Yoo KY. Alcohol drinking, cigarette smoking and risk of colorectal cancer in the Korean multi-center cancer cohort. Journal of Cancer Prevention 2015; 20147-52.
  76. Fuchs CS, Colditz GA, Stampfer MJ, Giovannucci EL, Hunter DJ, Rimm EB. A prospective study of cigarette smoking and the risk of pancreatic cancer. Archives of Internal Medicine 1996; 1562255-60.
  77. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. Journal of the National Cancer Institute 1994; 86183-91.
  78. Newcomb PA, Storer BE, Marcus PM. Cigarette smoking in relation to risk of large bowel cancer in women. Cancer Research 1995; 554906-9.
  79. Paskett ED, Reeves KW, Rohan TE, Allison MA, Williams CD, Messina CR. Association between cigarette smoking and colorectal cancer in the Womens´ Health Initiative. Journal of the National Cancer Institute 2007; 991729-35.
  80. Paller CJ, Ye X, Wozniak PJ, Gillespie BK, Sieber PR, Greengold RH. A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer and Prostatic Diseases 2013; 1650-5.
  81. Chen J, Song Y, Zhang L. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies. Journal of Nutritional Science and Vitaminology 2013; 59213-23.
  82. Giovannucci E, Rimm EB, Ascherio A, Colditz GA, Spiegelman D, Stampfer MJ. Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prevention 1999; 8277-82.
  83. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, Schoenberg JB. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. Journal of the National Cancer Institute 1994; 861510-6.
  84. CS F, GA C, MJ S, EL G, DJ H, EB R. A prospective study of cigarette smoking and the risk of pancreatic cancer. Archives of internal medicine 1996; 1562255-60.
  85. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks´ Archives of Surgery 2008; 393535-45.
  86. Muscat JE, Stellman SD, Hoffmann D, Wynder EL. Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prevention 1997; 615-9.
  87. Health UDo SH. The health consequences of smoking: a report of the Surgeon General. 2004;
  88. Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. American Journal of Epidemiology 2009; 170403-13.
  89. Vida S, Richardson L, Cardis E, Krewski D, McBride M, Parent ME. Brain tumours and cigarette smoking: analysis of the INTERPHONE Canada case-control study. Environmental Health 2014; 1355-
  90. Chao A, Thun MJ, Henley SJ, Jacobs EJ, McCullough ML, Calle EE. Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The Cancer Prevention Study II. International Journal of Cancer 2002; 101380-9.
  91. Maekawa A, Mitsumori K. Spontaneous occurrence and chemical induction of neurogenic tumors in rats-influence of host factors and specificity of chemical structure. Critical Reviews in Toxicology 1990; 20287-310.
  92. Bogovski P, Bogovski S. Animal Species in which N-nitroso compounds induce cancer. International Journal of Cancer 1981; 27471-4.
  93. Hawkins BT, Egleton RD, Davis TP. Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. American Journal of Physiology. Heart and Circulatory Physiology 2005; 289H212-9.
  94. Connelly JM, Malkin MG. Environmental risk factors for brain tumors. Current Neurology and Neuroscience Reports 2007; 7208-14.
  95. Zheng T, Cantor KP, Zhang Y, Chiu BC, Lynch CF. Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa. Cancer Epidemiol Biomarkers Prevention 2001; 10413-4.
  96. Preston-Martin S, Mack W, Henderson BE. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Research 1989; 496137-43.
  97. Schlehofer B, Hettinger I, Ryan P, Blettner M, Preston-Martin S, Little J. Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. International Journal of Cancer 2005; 113116-25.
  98. Musicco M, Filippini G, Bordo BM, Melotto A, Morello G, Berrino F. Gliomas and occupational exposure to carcinogens: case-control study. American Journal of Epidemiology 1982; 116782-90.
  99. Ahlbom A, Navier IL, Norell S, Olin R, Spannare B. Nonoccupational risk indicators for astrocytomas in adults. American Journal of Epidemiology 1986; 124334-7.
  100. Hurley SF, McNeil JJ, Donnan GA, Forbes A, Salzberg M, Giles GG. Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. Journal of Epidemiology and Community Health 1996; 50442-6.
  101. Mills PK, Preston-Martin S, Annegers JF, Beeson WL, Phillips RL, Fraser GE. Risk factors for tumors of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology 1989; 8266-75.
  102. Holick CN, Giovannucci EL, Rosner B, Stampfer MJ, Michaud DS. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro-Oncology 2007; 9326-34.
  103. Benson VS, Pirie K, Green J, Casabonne D, Beral V, Study CMW. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. British Journal of Cancer 2008; 99185-90.
  104. Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. Journal of Neuro-Oncology 2004; 6857-69.
  105. Silvera SA, Miller AB, Rohan TE. Cigarette smoking and risk of glioma: a prospective cohort study. International Journal of Cancer 2006; 1181848-51.
  106. Schlehofer B, Kunze S, Sachsenheimer W, Blettner M, Niehoff D, Wahrendorf J. Occupational risk factors for brain tumors: results from a population-based case-control study in Germany. Cancer Causes & Control 1990; 1209-15.
  107. Schneider B, Pulhorn H, Rohrig B, Rainov NG. Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detection and Prevention 2005; 29440-7.
  108. Mandelzweig L, Novikov I, Sadetzki S. Smoking and risk of glioma: a meta-analysis. Cancer Causes & Control 2009; 201927-38.
  109. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F. Association of meningioma with reproductive factors. International Journal of Cancer 2006; 1191152-7.
  110. Preston-Martin S, Mack W. Gliomas and meningiomas in men in Los Angeles County: investigation of exposures to N-nitroso compounds. IARC Scientific Publications 1991; 197-203.
  111. Ryan P, Lee MW, North B, McMichael AJ. Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. International Journal of Cancer 1992; 5120-7.
  112. Wenbin D, Zhuo C, Zhibing M, Chen Z, Ruifan Y, Jie J. The effect of smoking on the risk of gallbladder cancer: a meta-analysis of observational studies. European Journal of Gastroenterology & Hepatology 2013; 25373-9.
  113. Aune D, Vatten LJ, Boffetta P. Tobacco smoking and the risk of gallbladder disease. 2016;
  114. Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Prevalence of gallstone disease in relation to smoking, alcohol use, obesity, and glucose tolerance: a study of self-defense officials in Japan. American Journal of Epidemiology 1992; 136787-94.
  115. Okamoto M, Yamagata Z, Takeda Y, Yoda Y, Kobayashi K, Fujino MA. The relationship between gallbladder disease and smoking and drinking habits in middle-aged Japanese. Journal of Gastroenterology 2002; 37455-62.
  116. Kratzer W, Kachele V, Mason RA, Muche R, Hay B, Wiesneth M. Gallstone prevalence in relation to smoking, alcohol, coffee consumption, and nutrition. The Ulm Gallstone Study. Scandinavian Journal of Gastroenterology 1997; 32953-8.
  117. Pastides H, Tzonou A, Trichopoulos D, Katsouyanni K, Trichopoulou A, Kefalogiannis N. A case-control study of the relationship between smoking, diet, and gallbladder disease. Archives of Internal Medicine 1990; 1501409-12.
  118. McMichael AJ, Baghurst PA, Scragg RK. A case-control study of smoking and gallbladder disease: importance of examining time relations. Epidemiology (Cambridge, Mass.) 1992; 3519-22.
  119. Kato I, Kato K, Akai S, Tominaga S. A case-control study of gallstones: a major risk factor for biliary tract cancer. Japanese Journal of Cancer Research 1990; 81578-83.
  120. Bernard SM, Cartwright RA, Darwin CM, Richards ID, Roberts B, OB’rien C. Hodgkins´ disease: case control epidemiological study in Yorkshire. British Journal of Cancer 1987; 5585-90.
  121. Newell GR, Rawlings W, Kinnear BK, Correa P, Henderson BE, Dworsky R. Case-control study of Hodgkins´ disease. I. Results of the interview questionnaire. Journal of the National Cancer Institute 1973; 511437-41.
  122. Monnereau A, Orsi L, Troussard X, Berthou C, Fenaux P, Soubeyran P. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study. Cancer Causes & Control 2008; 191147-60.
  123. Hjalgrim H, Ekstrom-Smedby K, Rostgaard K, Amini RM, Molin D, Hamilton-Dutoit S. Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study. Cancer 2007; EpidemiologyBiomarkers & Prevention 16-
  124. Fernberg P, Odenbro A, Bellocco R, Boffetta P, Pawitan Y, Adami J. Tobacco use, body mass index and the risk of malignant lymphomas-a nationwide cohort study in Sweden. International Journal of Cancer 2006; 1182298-302.
  125. Briggs NC, Hall HI, Brann EA, Moriarty CJ, Levine RS. Cigarette smoking and risk of Hodgkins´ disease: a population-based case-control study. American Journal of Epidemiology 2002; 1561011-20.
  126. Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D. Childhood social environment and Hodgkins´ lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prevention 2004; 131361-70.
  127. Nieters A, Rohrmann S, Becker N, Linseisen J, Ruediger T, Overvad K. Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition. American Journal of Epidemiology 2008; 1671081-9.
  128. Castillo JJ, Dalia S, Shum H. Meta-analysis of the association between cigarette smoking and incidence of Hodgkins´ Lymphoma. Journal of Clinical Oncology 2011; 293900-6.
  129. Sergentanis TN, Kanavidis P, Michelakos T, Petridou ET. Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease. European Journal of Cancer Prevention 2013; 22131-50.
  130. Kamper-J?rgensen M, Rostgaard K, Glaser SL, Zahm SH, Cozen W, Smedby KE. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Annals of Oncology : Official Journal of the European Society for Medical Oncology 2013; 242245-55.
  131. Stagnaro E, Ramazzotti V, Crosignani P, Fontana A, Masala G, Miligi L. Smoking and hematolymphopoietic malignancies. Cancer Causes & Control 2001; 12325-34.
  132. Franceschi S, Serraino D, Bidoli E, Talamini R, Tirelli U, Carbone A. The epidemiology of non-Hodgkins´ lymphoma in the north-east of Italy: a hospital-based case-control study. Leukemia Research 1989; 13465-72.
  133. Nelson RA, Levine AM, Marks G, Bernstein L. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkins´ lymphoma. British Journal of Cancer 1997; 761532-7.
  134. Stagnaro E, Tumino R, Parodi S, Crosignani P, Fontana A, Masala G. Non-Hodgkins´ lymphoma and type of tobacco smoke. Cancer Epidemiol Biomarkers Prevention 2004; 13431-7.
  135. Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B. A case-control study of tobacco use and other non-occupational risk factors for t(14;18) subtypes of non-Hodgkins´ lymphoma (United States). Cancer Causes & Control 2002; 13159-68.
  136. Freedman DS, Tolbert PE, Coates R, Brann EA, Kjeldsberg CR. Relation of cigarette smoking to non-Hodgkins´ lymphoma among middle-aged men. American Journal of Epidemiology 1998; 148833-41.
  137. Fabbro-Peray P, Daures JP, Rossi JF. Environmental risk factors for non-Hodgkins´ lymphoma: a population-based case-control study in Languedoc-Roussillon, France. Cancer Causes & Control 2001; 12201-12.
  138. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich A, Fritschi L. Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. International Journal of Cancer 2004; 110429-34.
  139. Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB. Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leukemia & Lymphoma 2000; 37341-9.
  140. Besson H, Renaudier P, Merrill RM, Coiffier B, Sebban C, Fabry J. Smoking and non- Hodgkins´ lymphoma: a case-control study in the Rhone-Alpes region of France. Cancer Causes & Control 2003; 14381-9.
  141. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer 2005; EpidemiologyBiomarkers & Prevention 14-
  142. Schollkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Gadeberg O, Roos G. Cigarette smoking and risk of non-Hodgkins´ lymphoma-a population-based case-control study. Cancer 2005; EpidemiologyBiomarkers & Prevention 14-
  143. Diver WR, Patel AV, Thun MJ, Teras LR, Gapstur SM. The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study. Cancer Causes & Control 2012; 231231-40.
  144. Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y. Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. British Journal of Cancer 2003; 892087-92.
  145. Diver WR, Teras LR, Gaudet MM, Gapstur SM. Exposure to environmental tobacco smoke and risk of non-Hodgkin lymphoma in nonsmoking men and women. American Journal of Epidemiology 2014; 179987-95.
  146. Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002; 942490-501.
  147. Nawar E, Mbulaiteye SM, Gallant JE, Wohl DA, Ardini M, TH. Risk factors for Kaposis´ sarcoma among HHV-8 seropositive homosexual men with AIDS. International Journal of Cancer 2005; 115296-300.
  148. Song F, Qureshi AA, Gao X, Li T, Han J. Smoking and risk of skin cancer: a prospective analysis and a meta-analysis. International Journal of Epidemiology 2012; 411694-705.
  149. Anderson LA, Lauria C, Romano N, Brown EE, Whitby D, Graubard BI. Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer 2008; EpidemiologyBiomarkers & Prevention 17-
  150. Moore PS, Chang Y. Kaposis´ sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. American Journal of Epidemiology 1998; 147217-21.
  151. Rady PL, Yen A, Martin RW, Nedelcu I, Hughes TK, Tyring SK. Herpesvirus-like DNA sequences in classic Kaposis´ sarcomas. Journal of Medical Virology 1995; 47179-83.
  152. Brown EE, Fallin D, Ruczinski I, Hutchinson A, Staats B, Vitale F. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer 2006; EpidemiologyBiomarkers & Prevention 15-
  153. Whitby D, Luppi M, Sabin C, Barozzi P, Biase ARD, Balli F. Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. British Journal of Cancer 2000; 82702-4.
  154. Hoover DR, Black C, Jacobson LP, Martinez-Maza O, Seminara D, Saah A. Epidemiologic analysis of Kaposis´ sarcoma as an early and later AIDS outcome in homosexual men. American Journal of Epidemiology 1993; 138266-78.
  155. Goedert JJ, Scoppio BM, Pfeiffer R, Neve L, Federici AB, Long LR. Treatment of classic Kaposi sarcoma with a nicotine dermal patch: a phase II clinical trial. Journal of the European Academy of Dermatology and Venereology 2008; 221101-9.
  156. Chang J, Renne R, Dittmer D, Ganem D. Inflammatory cytokines and the reactivation of Kaposis´ sarcoma-associated herpesvirus lytic replication. Virology 2000; 26617-25.
  157. Guttman-Yassky E, Dubnov J, Kra-Oz Z, Friedman-Birnbaum R, Silbermann M, Barchana M. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?. Cancer 2006; 106413-9.
  158. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS (London, England) 1996; 101121-6.
  159. Secretan B, Straif K, Baan R, Grosse Y, Ghissassi FE, Bouvard V. A review of humancarcinogens–Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. 2009;
  160. Wensveen CA, Bastiaens MT, Kielich CJ, Berkhout MJ, Westendorp RG, Vermeer BJ, Cancer SLS. Relation between smoking and skin cancer. Journal of Clinical Oncology 2001; 19231-8.
  161. Odenbro A, Gillgren P, Bellocco R, Boffetta P, Hakansson N, Adami J. The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. British Journal of Dermatology 2007; 15699-105.
  162. Boyd AS, Shyr Y, King LE. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. Journal of the American Academy of Dermatology 2002; 46706-9.
  163. Freedman DM, Sigurdson A, Doody MM, Mabuchi K, Linet MS. Risk of basal cell carcinoma in relation to alcohol intake and smoking. Cancer Epidemiol Biomarkers Prevention 2003; 121540-3.
  164. Kessides MC, Wheless L, Hoffman-Bolton J, Clipp S, Alani RM, Alberg AJ. Cigarette smoking and malignant melanoma: a case-control study. Journal of the American Academy of Dermatology 2011; 6484-90.
  165. DeLancey JO, Hannan LM, Gapstur SM, Thun MJ. Cigarette smoking and the risk of incident and fatal melanoma in a large prospective cohort study. Cancer Causes & Control 2011; 22937-42.
  166. Yerger VB, Malone RE. Melanin and nicotine: A review of the literature. Nicotine & Tobacco Research 2006; 8487-98.
  167. Mills CM, Hill SA, Marks R. Transdermal nicotine suppresses cutaneous inflammation. Archives of Dermatology 1997; 133823-5.
  168. Mills CM, Hill SA, Marks R. Altered inflammatory responses in smokers. BMJ (Clinical Research Ed.) 1993; 307911-2.
  169. Freedman DM, Sigurdson A, Doody MM, Rao RS, Linet MS. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes & Control 2003; 14847-57.
  170. Hallquist A, Hardell L, Degerman A, Boquist L. Occupational exposures and thyroid cancer: results of a case-control study. European Journal of Cancer Prevention 1993; 2345-9.
  171. Galanti MR, Hansson L, Lund E, Bergstrom R, Grimelius L, Stalsberg H. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiol Biomarkers Prevention 1996; 5425-31.
  172. Kreiger N, Parkes R. Cigarette smoking and the risk of thyroid cancer. European Journal of Cancer 2000; (OxfordEngland) 36-
  173. Jee SH, Samet JM, Ohrr H, Kim JH, Kim IS. Smoking and cancer risk in Korean men and women. Cancer Causes & Control 2004; 15341-8.
  174. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. American Journal of Epidemiology 2010; 171242-52.
  175. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. International Journal of Cancer 2001; 93745-50.
  176. Mack WJ, Preston-Martin S, Bernstein L, Qian D. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Annals of Epidemiology 2002; 12395-401.
  177. Zivaljevic V, Vlajinac H, Marinkovic J, Paunovic I, Diklic A, Dzodic R. Cigarette smoking as a risk factor for cancer of the thyroid in women. Tumori 2004; 90273-5.
  178. Kitahara CM, Linet MS, Freeman LEB, Check DP, Church TR, Park Y. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes & Control 2012; 231615-24.
  179. Mack WJ, Preston-Martin S, Maso LD, Galanti R, Xiang M, Franceschi S. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes & Control 2003; 14773-85.
  180. Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). The Journal of Clinical Endocrinology and Metabolism 2004; 896077-86.
  181. Soldin OP, Goughenour BE, Gilbert SZ, Landy HJ, Soldin SJ. Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid 2009; 19817-23.
  182. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. The Journal of Clinical Endocrinology and Metabolism 2006; 914295-301.
  183. Kumar A, Klinge CM, Goldstein RE. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. International Journal of Oncology 2010; 361067-80.
  184. Shiels MS, Rohrmann S, Menke A, Selvin E, Crespo CJ, Rifai N. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes & Control 2009; 20877-86.

Comments